Madison, Wis. (Feb 24, 2022) ‒ Mirus Bio, a leading provider of delivery solutions within Gamma Biosciences, today launched TransIT-VirusGEN® SELECT Transfection Kits for large-scale viral vector production for cell and gene therapy applications. The kits support pre-clinical and process development activities and consist of the TransIT-VirusGEN® Transfection Reagent, complex formation solution and enhancer. The full kits are […]
Menlo Park CA and Madison, WI (December 14, 2021) – Gamma Biosciences, a global life sciences company serving the academic and advanced therapy market, today announced the appointment of Dale Gordon as Chief Executive Officer (CEO) of its operating company Mirus Bio. Gordon succeeds founders Jon Wolff and Jim Hagstrom in carrying the scientific legacy of the […]
Madison, Wis. (August 5, 2021) – Mirus Bio, an innovator in transfection technologies, today announces the launch of the TransIT® VirusGEN® GMP product line. This expansion to the existing TransIT® VirusGEN® product line is compliant with good manufacturing practice (GMP) viral vector manufacturing to support cell and gene therapy development and process activities through to GMP commercial […]
Madison, WI and Menlo Park, CA (May 18, 2021) – Mirus Bio, an innovator in transfection technologies announced that they are entering into a partnership with Gamma Biosciences, a global life sciences company serving the advanced therapy market. Gamma has agreed to make a controlling investment in Mirus Bio. Current Mirus shareholders will retain a substantial […]
Madison, Wis. (July 25, 2019) ‒ The TransIT-VirusGEN® SELECT Transfection Reagent is developed for large-scale virus production for preclinical and early phase clinical trials and is identical in formulation to the fully synthetic and animal-origin-free, research-grade TransIT-VirusGEN® Transfection Reagent. TransIT-VirusGEN® SELECT is differentiated from the research-grade reagent by additional quality release testing that simplifies the process of qualifying ancillary […]
Madison, Wis. (May 1, 2019) ‒ Researchers now have an opportunity to achieve higher protein yields from transient transfection of suspension CHO cells. The CHOgro® High Yield Expression System is a fully optimized, second-generation protein expression platform featuring the CHOgro® Titer Enhancer, which increases the speed and overall yield of the system. Benefits of the new […]
Madison, Wis. (November 8, 2017) ‒ Life science researchers now have a single transfection formulation to allow them to produce consistent and high functional titers of adeno-associated virus (AAV) and lentivirus. The new TransIT-VirusGEN® Transfection Reagent is ideal for adeno-associated virus (AAV) and lentivirus production in adherent and suspension cell cultures, and is scalable. TransIT-VirusGEN® Transfection Reagent […]
[April 25, 2017] With the increasing need to visually track nucleic acid post-delivery to cells, the NEW Label IT® Nucleic Acid Labeling Kit, MFP488 provides a more robust option for nucleic acid labeling than traditional fluorescein methods. Researchers can look forward to these benefits using the Label IT®-MFP488: For a limited time, the Label IT® MFP488 will be available at an […]
High Yield Transfection and Baculovirus Production in Insect Cells [Madison, WI December 11, 2013] If low protein expression in insect cells is bugging you, consider the NEW TransIT®-Insect Transfection Reagent. Insect cells are a powerful platform for generating recombinant baculovirus and for producing high-levels of soluble, functional protein. TransIT®-Insect is an animal-origin free transfection reagent specifically optimized […]
New High Performance Broad Spectrum Transfection System, Capable of Delivering DNA and siRNA [Madison, WI July 31, 2013] Mirus Bio has expanded its transfection expertise with the development of the TransIT-X2® Dynamic Delivery System, an innovative polymeric system for high efficiency nucleic acid delivery. TransIT-X2® can be used for independent or simultaneous delivery of DNA and siRNA. […]